Thanks for submitting the form. A member from PointCross Life Sciences will get in touch with you shortly regarding your request for a demo.
Check out some of our latest blog posts:
October 2025
Bridging the Gap: How Natural Language AI Can Transform Clinical Data Access
As the BioPharma industry evolves toward more data-intensive, portfolio-wide agile decision-making, under pressure to innovate and reduce the time to market, organizations that master bridging the questions of their staff to regulatory compliant, verifiable responses retrieved from their study data systems will move faster, decide smarter, and ultimately bring therapies to patients more efficiently,...
September 2025
Ask with Ease. Retrieve with Rigor. Study Data Secured by RAG-Enabled Chat in Xbiom
The biopharmaceutical industry is entering a new era where the ability to harness data directly determines the speed and success of drug development. Clinical trials, nonclinical studies, and biomarker assays now generate massive volumes of complex data. When unified and made accessible, clinical trial data accelerates insights, strengthens regulatory confidence, and reduces development risk. PointCross enables...
How Leaders Can Shape Drug Success Through Data
The Case for Faster, Smoother Approvals Every day saved in the approval process matters. Faster reviews mean therapies reach patients sooner, investors see value earlier, and science delivers its impact without avoidable setbacks. The encouraging news is that most delays are not because science failed. They happen because submissions were not fully supported by strong data...
August 2025
The Hidden Bottleneck Undermining Pharma’s Mission
Every pharma executive faces the same core challenge: developing safe, efficacious therapies that reach patients while delivering sustainable returns. The industry exists for one fundamental purpose: to discover, develop, and deliver innovative treatments that are both clinically proven and commercially viable. Yet despite record R&D investments, most companies are trapped in cycles that work against...
The AI Revolution CMOs & CSOs Need Now
Modern pharmaceutical companies take a different path on their journey into the digital age. CMOs and CSOs must have a say. If you’re a Chief Medical Officer, Chief Scientific Officer or Clinical Development leader, you know the frustration all too well: your teams are wrangling data from multiple sources, electronic data capture systems, labs, patient-reported...
Enterprise LLMs for BioPharma Therapeutics Development
Abstract Large Language Models (LLMs) have the potential to significantly accelerate therapeutics development while reducing costs and increasing innovation in the biopharmaceutical industry. However, two critical barriers prevent widespread adoption of this technology. First, competitive sensitivities and data sovereignty requirements mandate that clinical trial and nonclinical study data remain within pharmaceutical companies' secure networks. This necessitates...
PointCross at PHUSE SDE 2025 – South San Francisco
Date: Friday, 22 August 2025Location: Genentech, 350 DNA Way, South San Francisco, CA 94080 Event Theme: Revolutionising Healthcare: The Transformative Power of Data Analytics and AI The PHUSE SDE 2025 brought together experts from healthcare, technology, and regulatory sectors to explore how advanced analytics, machine learning, and predictive modelling are transforming healthcare and drug development. Discussions...
Breaking Free from Clinical Data Chaos: The AI Revolution CMOs & CSOs Need Now
How modern pharmaceutical companies can finally catch up with the digital age If you're a Chief Medical Officer, Chief Scientific Officer or Clinical Development leader, you know the frustration all too well. Your teams are drowning in data from multiple sources, electronic data capture systems, labs, patient-reported outcomes, and real-world evidence, but somehow, getting actionable...